Osteoporosis
Conditions
Interventions
Observational group:None
Sponsors
The First Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Age
45 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Patients undergoing teriparatide treatment; 2.Lumbar spine or single hip bone mineral density (BMD) T-score < -3.0; 3.Postmenopausal osteoporosis diagnosis; 4.Very high fracture risk classification
Exclusion criteria
Exclusion criteria: 1.Patients with teriparatide hypersensitivity; 2.Patients with creatinine clearance <35 mL/min; 3.Patients with Paget's disease of bone, history of skeletal radiotherapy, bone metastases, or concurrent hypercalcemia; 4.Adolescents under 18 years old or those with open epiphyses; 5.Patients with hyperparathyroidism
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Bone mineral density (BMD).;Bone metabolism;Other laboratory tests (including parathyroid hormone, serum calcium, serum phosphorus, serum vitamin D, complete blood count, liver function, renal function, and erythrocyte sedimentation rate); | — |
Primary
| Measure | Time frame |
|---|---|
| Medication adherence; | — |
Countries
China
Contacts
Public ContactWei Jiang
The First Affiliated Hospital of Chongqing Medical University
Outcome results
None listed